Alex Thurman
Director of Finance/CFO chez GLAUKOS CORPORATION
Fortune : 5 M $ au 31/03/2024
Profil
Alex Thurman is currently the Chief Financial Officer & Senior Vice President at Glaukos Corp.
and the Vice President-Finance at Allergan Ltd.
(Ireland).
He has an undergraduate and graduate degree from Brigham Young University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GLAUKOS CORP
0,11% | 08/04/2024 | 52 532 ( 0,11% ) | 5 M $ | 31/03/2024 |
Postes actifs de Alex Thurman
| Sociétés | Poste | Début |
|---|---|---|
| GLAUKOS CORPORATION | Director of Finance/CFO | 01/04/2022 |
| ALLERGAN PLC | Director of Finance/CFO | 01/12/2016 |
Formation de Alex Thurman
| Brigham Young University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GLAUKOS CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
